Home / Biotechnology / Recombinan

Recombinant Vaccines Market By Disease (Infectious Diseases, Cancer) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Vaccines plays a significant role in prevention and control of different forms of infectious diseases. In the previous years, killed or attenuated vaccines were used, while gradually transitioning to recombinant subunit approach in the last two decades. Use of recombinant technologies in production of subunit vaccines makes a process more simplified, safe and cost effective. A recombinant vaccine is manufactured by using recombinant DNA technology and it offers prime advantage that there is complete absence of pathogens during the production and purification procedure, thus making the production procedure safer.  

The research study titled “Recombinant Vaccines Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” covers in-depth information related to recombinant vaccines market. The research study provides comprehensive analysis based on different market segments such as disease type and geography. Infectious diseases and cancer are covered in disease type segment analysis. Infectious diseases segment is further classified as hepatitis B infection, herpes zoster infection, influenza infection and other infectious diseases. 

North America (comprising United States and Canada), Europe (with United Kingdom and Germany), Asia Pacific (including Japan and China), Latin America (comprising Mexico and Brazil) and Middle East and Africa (GCC) cumulatively form the global recombinant vaccines market. Market size and forecast for these regions along with their cross-sectional segmentation are provided in this report for the considered period. The regional markets are further studied in terms of major country specific markets.

Quantitative data and qualitative information are included in this report for further understanding about the current market situation and future scenarios. Information such as market dynamics (drivers, opportunities and challenges) gives the detailed idea about the current developments in the global recombinant vaccines market. In order to help strategic decisions about the recombinant vaccines market, competitive profiling of the prominent players, attractive investment proposition, and market position of key leaders involved in the global recombinant vaccine market also included in report.  

Recombinant Vaccines Market

Choose License Type
Published Date:  Nov 2017
Category:  Biotechnology
Report ID:   58819
Report Format:   PDF
Pages:   120
Rating:    4.1 (40)
Connect With Us
24/7 Research Support